BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37694164)

  • 1. Effects of star ratings bonus payments on disparities in medication utilization issues.
    Tsang CCS; Garuccio J; Dong X; Sim Y; Wang J
    Explor Res Clin Soc Pharm; 2023 Sep; 11():100323. PubMed ID: 37694164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012.
    Li P; Doshi JA
    PLoS One; 2016; 11(5):e0154357. PubMed ID: 27149092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Medicare Advantage Star Ratings With Racial, Ethnic, and Socioeconomic Disparities in Quality of Care.
    Meyers DJ; Rahman M; Mor V; Wilson IB; Trivedi AN
    JAMA Health Forum; 2021 Jun; 2(6):e210793. PubMed ID: 35977175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial incentives tied to Medicare star ratings: impact on influenza vaccination uptake in Medicare beneficiaries.
    Stuart B; Loh FE; Kamal-Bahl S; Vietri J; Bakken D; Puckett J; Doshi JA
    Am J Manag Care; 2022 Jun; 28(6):273-280. PubMed ID: 35738223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic disparities in access to and enrollment in high-quality Medicare Advantage plans.
    Park S; Werner RM; Coe NB
    Health Serv Res; 2023 Apr; 58(2):303-313. PubMed ID: 35342936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.
    Dong X; Tsang CCS; Browning JA; Sim Y; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J
    Curr Med Res Opin; 2023 Jul; 39(7):963-971. PubMed ID: 37219396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Medicare Advantage Star Ratings With Racial and Ethnic Disparities in Hospitalizations for Ambulatory Care Sensitive Conditions.
    Park S; Werner RM; Coe NB
    Med Care; 2022 Dec; 60(12):872-879. PubMed ID: 36356289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities associated with Medicare Part D Star Ratings measures among patients with Alzheimer's disease and related dementias.
    Tsang CCS; Zhang X; Barenie RE; Cernasev A; Miller NA; Wan JY; Tsao JW; Wang J
    Medicine (Baltimore); 2023 May; 102(18):e33641. PubMed ID: 37144996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Part D Star Ratings on racial and ethnic disparities in health care costs.
    Tsang CCS; Sim Y; Christensen ML; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100250. PubMed ID: 37091627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
    Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Incentive Payments in Medicare Advantage's Pay-for-Performance Program Did Not Improve Quality But Did Increase Plan Offerings.
    Layton TJ; Ryan AM
    Health Serv Res; 2015 Dec; 50(6):1810-28. PubMed ID: 26549194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing racial/ethnic disparities associated with Medicare Part D Star Ratings among population with Alzheimer's disease and related dementias.
    Tsang CCS; Wang J
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):1067-1075. PubMed ID: 37551695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and ethnic disparities associated with the measure for drug-drug interactions among Medicare beneficiaries.
    Browning J; Tsang CCS; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Dong X; Wang J
    J Am Pharm Assoc (2003); 2022; 62(1):142-149. PubMed ID: 34509379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and ethnic disparities due to Medicare Part D Star Ratings criteria among kidney transplant patients with diabetes, hypertension, and/or dyslipidemia.
    Chisholm-Burns MA; Spivey CA; Tsang CCS; Wang J
    J Manag Care Spec Pharm; 2022 Jun; 28(6):688-699. PubMed ID: 35621720
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
    Dong X; Tsang CCS; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Browning JA; Garuccio J; Zeng R; Wang J
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100420. PubMed ID: 38420610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.